Evidence-Based Optimization Research of Yi Qi Wen Yang method in chronic heart failure based o
- Conditions
- heart failure
- Registration Number
- ITMCTR2200006075
- Lead Sponsor
- Jiangsu Provincial Hospital of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Age 18-75 years old, gender is not limited; 2. Decreased chronic ejection fraction in accordance with the China Heart Failure Diagnosis and Treatment Guidelines 2018 (LVEF=40%)Patients with heart failure (HFrEF), NYAH class II-IV, and resting heart rate> 55b.p.m., blood pressure= 90/60mmHg, stable condition can be followed up regularly and monitor heart rate, blood pressure at home; 3. TCM dialectics belong to the heart (qi) yang deficiency, stasis obstructed with water; 4. Voluntarily agree to participate in the trial, and be able to adhere to follow-up and go to the hospital on their own.
1. Patients with severe hepatic and renal insufficiency, or serious primary diseases of malignant tumors, endocrine, nervous, blood and other systems; 2. Patients with contraindications to the use of ACE/ARB/ARNI, ß receptor blockers, aldosterone antagonists; 3. All factors that can increase the mortality rate: such as cardiogenic shock, malignant arrhythmias, severe valvular disease that has not been surgically repaired, obstructive hypertrophic cardiomyopathy, acute pulmonary edema, pulmonary embolism, severe infection, refractory end-stage heart failure, etc. are not suitable for inclusion; 4. Patients with cognitive impairment or severe psychiatric symptoms; 5. Pregnant or lactating women, as well as those who are allergic to multiple drugs;6.Currently involved in other clinical trials.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ß receptor blockers, ACE/ARB/ARNI dosages;
- Secondary Outcome Measures
Name Time Method TCM Syndrome Points;Cardiac ultrasound;NYHA class;Kansas City Cardiomyopathy Questionnaire;Plasma BNP;